PathAI's machine learning tools analyze pathology images to help detect cancer more accurately and consistently across pathologists, assisting with biomarker quantification and clinical trial eligibility assessment. It's aimed at reducing the real variability that exists between different pathologists reading the same slide.
It's easier when you're signed in — Altern helps you get more out of AI.
By continuing you agree to our Terms and Privacy Policy.